U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 36 results

Status:
US Approved Rx (2002)
First approved in 1996

Class (Stereo):
CHEMICAL (ACHIRAL)



Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no ...
Status:
US Approved Rx (2012)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cisatracurium is a cis-cis isomer of atracurium and five time as potent as atracurium. The drug is approved by FDA and marketed under the name Nimbex. It is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to prov...
Status:
US Approved Rx (2016)
First approved in 1981

Class (Stereo):
CHEMICAL (ABSOLUTE)



Vecuronium is a neuromuscular blocking agent. Vecuronium operates by competing for the cholinoceptors at the motor end plate thereby exerting its muscle-relaxing properties which are used adjunctively to general anesthesia. Vecuronium is a bisquatern...
Status:
US Approved Rx (1995)
First approved in 1977

Class (Stereo):
CHEMICAL (ACHIRAL)



Cyclobenzaprine is a centrally-acting muscle relaxant which boosts levels of norepinephrine and binds to serotonin receptors in the brain to reduce spasm. Cytochromes P-450 3A4, 1A2, and, to a lesser extent, 2D6, mediate N-demethylation, one of the o...
Status:
US Approved Rx (2007)
First approved in 1977

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Baclofen (brand names Kemstro, Lioresal, and Gablofen) is a derivative of gamma-aminobutyric acid (GABA). Baclofen is a muscle relaxer and an antispastic agent and is used to treat muscle symptoms caused by multiple sclerosis, including spasm, pain, ...
Status:
US Approved Rx (2014)
First approved in 1974

Class (Stereo):
CHEMICAL (ACHIRAL)



Dantrolene is a drug which was approved by FDA for the treatment of chronic spasticity and malignant hyperthermia (a rare life-threatening clinical syndrome). Dantrolene effect was shown both in vivo and in vitro and proved to be mediated by interact...
Status:
US Approved Rx (1990)
First approved in 1972

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Pancuronium (trademarked as Pavulon) is an aminosteroid muscle relaxant with various medical uses. Pancuronium is a typical non-depolarizing curare-mimetic muscle relaxant. It competitively inhibits the nicotinic acetylcholine receptor at the neuromu...
Status:
US Approved Rx (1989)
First approved in 1959

Class (Stereo):
CHEMICAL (RACEMIC)



A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal condi...
Status:
US Approved Rx (2023)
First approved in 1958

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Chlorzoxazone is a centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits multisyna...
Status:
US Approved Rx (1982)
First approved in 1957

Class (Stereo):
CHEMICAL (RACEMIC)



Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class used to treat muscle pain and to help with motor control in Parkinson's disease but has largely been superseded by newer drugs. Orphenadrine binds and inhibits both hista...